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Nanoparticle research has greatly benefitted medical imaging platforms by 
generating new signals, enhancing detection sensitivity, and expanding both clini-
cal and preclinical applications. For magnetic resonance imaging, the fabrication 
of superparamagnetic iron oxide nanoparticles has provided a means of detecting 
cells and has paved the way for magnetic particle imaging. As the field of molecular 
imaging grows and enables the tracking of cells and their molecular activities so 
does the possibility of tracking genetically programmed biomarkers. This chapter 
discusses the advantages and challenges of gene-based contrast, using the bacterial 
magnetosome model to highlight the requirements of in vivo iron biomineralization 
and reporter gene expression for magnetic resonance signal detection. New infor-
mation about magnetosome protein interactions in non-magnetic mammalian cells 
is considered in the light of design and application(s) of a rudimentary magneto-
some-like nanoparticle for molecular imaging. Central to this is the hypothesis that 
a magnetosome root structure is defined by essential magnetosome genes, whose 
expression positions the biomineral in a given membrane compartment, in any cell 
type. The use of synthetic biology for programming multi-component structures 
not only broadens the scope of reporter gene expression for molecular MRI but also 
facilitates the tracking of cell therapies.
Keywords: magnetosome, iron biomineral, reporter gene expression, iron contrast, 
magnetic resonance imaging
1. Introduction
With over a 20-year history, the field of molecular imaging is now well-
entrenched [1–3] and continuing to expand its influence over multiple imaging 
modalities, including optical [4], nuclear [5], magnetic resonance (MR) [6] and 
acoustic [7]. In all these platforms, the use of contrast agents is a central theme, 
to enhance tissue structure and differentiate between healthy and diseased cells. 
Image-guidance has been achieved with simple molecules like the fluorophore 
indocyanin green [8], with macromolecules like antibodies [9], and with synthetic 
particles like superparamagnetic iron oxides (SPIO) [10] or perfluorocarbon emul-
sions [11]. Moreover, by adding targeting groups to these contrast agents, additional 
tissue specificity and/or image resolution may be obtained.
Despite these attributes, there are challenges in biomarker development for 
medical imaging, such as longevity of the signal and intrinsic biological activity. 
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Exogenous contrast agents that reach their cellular targets may still be lost during 
cell division, metabolized, or decay too rapidly for effective longitudinal study. In 
addition, their role as beacon does not necessarily provide a measure of inherent 
biological activity. One solution is to adopt a gene-based approach in which contrast 
is synthesized by the cell and thus remains with it throughout its life cycle. Not only 
does this type of endogenous contrast get passed to daughter cells, it also permits 
reporter gene expression in response to biological cues. In this way, using the tools 
of molecular biology, cellular contrast may be directly linked to the presence of 
proteins (i.e. transcription factors, TF) that regulate genetically programmed 
contrast gene expression [12]. This approach has been tremendously effective with 
fluorescent proteins and the optical detection of cells and tissues, where depth of 
penetration is low enough to avoid losses in sample resolution from the scatter of 
light. Addressing gene-based contrast for other types of non-invasive detection 
systems is, in general, still a work in progress.
In this chapter, the development of gene-based contrast for MR detection will be 
described using the bacterial magnetosome as a model for biogenic iron biominer-
als. Integral to this discussion are the factors that regulate gene expression, deter-
mine protein localization, guide macromolecular assembly, and permit iron crystal 
formation without the need for exogenous contrast agent.
2. Magnetosome model
The magnetosome is a remarkable structure synthesized by magnetotactic 
bacteria (MTB) [13]. These micron size cells produce nanometer size iron crystals 
for magnetotaxis, responding to the earth’s magnetic field through the creation of 
a single magnetic dipole within each biomineral. Ingeniously, to avoid cytotoxicity 
associated with the oxidation and reduction of iron, crystallization proceeds within 
a protective compartment, i.e. a vesicle invaginated from the cell’s innermost plasma 
membrane [14]. Arguably one of the earliest examples of a subcellular organelle 
[15, 16], magnetosomes are typically arranged in a defined pattern within the cell 
and connected to cytoskeletal protein (Figure 1) [17]. Importantly, various magne-
tosome membrane (Mam) proteins and magnetosome membrane specific (Mms) 
proteins enable the compartment to carry out its functions [18]: recruiting the 
necessary activities to define the vesicle, connecting the magnetosomes to cytoskel-
etal elements, concentrating iron, defining the crystal, and assembling individual 
magnetosomes into an effective magnet.
In MTB, magnetosome biosynthesis is thus a protein-directed process, geneti-
cally encoded by structural genes arranged in units, termed operons, and located 
largely in a gene cluster, termed the magnetosome genomic island. Of the approxi-
mately 30 genes involved in magnetosome formation, roughly one third are located 
elsewhere in the bacterial genome, possibly indicative of magnetosome protein 
interactions with common cellular components. In support of this, mammalian 
cation diffusion facilitator protein complements bacterial MamM function [19]. In 
addition, mammalian molecular motors appear to interact with MamL [20]. While 
more studies are required to fully elucidate magnetosome structure, and potentially 
reproduce it in other cell types, the following functional categorization may prove 
useful for dissecting the steps and partners involved in magnetosome formation.
2.1 Membrane designation
Mutations designed to delete individual magnetosome genes from MTB 
have exposed the absolute requirement of a select few genes for magnetosome 
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production. When anyone of these essential genes is missing, there is either no 
magnetosome vesicle and/or no biomineral [21]. Among these genes are mamB, 
mamE, mamI and mamL. Numerous other genes may be selectively deleted without 
damaging the entire magnetosome structure [13]. In this case, what results is a 
compromised biomineral with a less than perfect crystal, altered size or disruption 
in cellular location. As the genes responsible for various magnetosome attributes 
become clearer so does the opportunity for designing nanoparticles that are not 
only compatible with a given intracellular environment but also impart desirable 
magnetic properties [22, 23]. For magnetic resonance imaging (MRI), subcellular 
arrangement of magnetosomes through MamJ-MamK interactions [24] may be a 
dispensable feature. Likewise, in magnetic particle imaging (MPI) individual mag-
netosomes constitute an ideal tracer owing to their perfect crystal morphology [25].
With a view to forming a rudimentary magnetosome-like nanoparticle in any 
cell type, we have proposed that essential magnetosome genes constitute a common 
base upon which diverse biominerals are synthesized [22]. This notion is predicated 
Figure 1. 
Magnetosome crystal morphologies. Transmission electron microscopy of MTB shows three types of magnetite 
crystal: cubooctahedral (A), prismatic (B) and bullet-shaped (C). Size, shape, composition, and subcellular 
arrangement of magnetosomes is generally species-specific. Adapted from Vargas et al. [17].
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on the specificity of certain protein–protein interactions, needed to establish the 
magnetosome as a distinct structure. Plausibility is evident based on genomic 
sequencing and the commonality of sequence across diverse classes of MTB [26]. 
Likewise, large scale magnetosome gene expression has been successfully tested in 
a non-magnetic bacterium [27]. In this work, magnetosome related operons from 
the magnetotactic bacterium Magnetospirillum gryphiswaldense were transferred 
to the non-magnetic bacterium Rhodospirillum rubrum. Characterization of newly 
imparted magnetic properties included the appearance of intracellular, electron 
dense particles by transmission electron microscopy, with Fourier transforms in 
high-resolution images displaying intensity maxima typical of magnetite. In addi-
tion, magnetically transformed R. rubrum continued to perform photosynthesis, 
indicating compatibility between magnetosome-like nanoparticles and normal cel-
lular function. Nevertheless, the minimum number of magnetosome genes required 
to build the basic magnetosome unit has not been clearly defined. Moreover, this 
knowledge would greatly enable the rational use of synthetic biology aimed at 
tailoring magnetosome-like nanoparticles for multiple purposes, above and beyond 
magnetotaxis, and in a wider variety of cell types.
Toward understanding the genetic make-up of a rudimentary magnetosome-like 
nanoparticle, MamI-MamL interactions have recently been described in a mam-
malian cell system [28]. This work showed that (1) MamI and MamL are compatible 
with a mammalian cell expression system; (2) MamL specifically recruits MamI to 
the same intracellular location despite co-expression in the complex intracellular 
environment of the mammalian host; and (3) MamL particles, alone and in the 
presence of MamI, also interact with putative mammalian molecular motors. These 
findings suggest that MamL may have a role in anchoring magnetosome assembly 
within a given membrane and raises the possibility that MamL also forms previ-
ously unrecognized cytoskeletal connections in MTB. Such a dual function further 
implies that membrane localization and magnetosome assembly may be initiated 
simultaneously, accounting for the essential role of MamL in both vesicle formation 
and subsequent biomineralization.
2.2 Protein recruitment
There are numerous corollaries to be considered for optimal expression of 
magnetosome-like nanoparticles in foreign non-magnetic cells. If the role of MamL 
is indeed to designate the membrane compartment, then eukaryotic cells equipped 
with vesicles may yet form magnetosomes by drawing on only those genes that 
attract biomineralizing activities (Figure 2). This would simplify magnetosome 
biosynthesis in eukaryotic cells. This is not to say that genetic encoding of vesicle 
formation should be ignored. A fuller understanding of how magnetosome vesicles 
form may be useful for ultrasound technologies that would benefit from reporter 
gene expression (discussed below). If the role of MamL lies in recruitment of 
magnetosome proteins involved in iron crystallization, then perhaps vesicle forma-
tion is largely carried out by other magnetosome proteins that shape the vesicle and 
accommodate biominerals of varying dimensions and morphologies [13, 21]. To 
this point, seven mam genes, including the essential ones (mamB, mamE, mamI and 
mamL) have been implicated in magnetosome membrane formation in MTB [29].
Interestingly, there may be a dual role for MamI in both iron crystal nucleation 
[30] and size of the magnetosome vesicle [31]. Using a mammalian expression 
system to substantiate this hypothesis, we showed that MamI-derived contrast 
significantly increases MRI transverse relaxivity over the parental control, when 
cells are cultured in the presence of an iron supplement [32]. In this work, cells 
were mounted in a spherical gelatin phantom and placed in a knee coil for scanning 
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at 3 Tesla using previously described MR sequences [33]. With this experimental 
setup, measurements obtained from a compact layer of cells can be assessed in any 
cell type, expression system and treatment condition. Using the same expression 
system and human melanoma cell line, the motility of fluorescent MamL particles 
increased in the presence of MamI, influencing both directed and Brownian motion 
and suggesting that particle size may be more compact in the presence of MamI 
[20]. These unexpected findings, from two small but essential magnetosome genes, 
reflect at once the beauty and simplicity of the MTB genome in its capacity to 
streamline the formation of magnetosomes using a minimum of genetic encoding.
2.3 Rudimentary nanoparticle
Given these findings, we might expect that the distinction between magneto-
some vesicle formation and iron biomineralization is not so clear-cut. A subset of 
magnetosome genes, perhaps the essential genes, may link the two fundamental 
processes that define the magnetosome, i.e. vesicle and biomineral, by recruiting 
proteins to a designated site on the membrane and establishing the base structure 
upon which the magnetosome is elaborated. In cells where the vesicle is otherwise 
formed, the key challenge is deciphering biomineralization. To this point, the 
reported activity of MamE fits into this framework [34, 35]. Also provisionally 
defined as a bifunctional protein, in the absence of MamE there is no biomineral, 
although, vesicle formation proceeds [21].
There is still much to learn about magnetosome assembly. Ideally, its forma-
tion in any cell can be accomplished by adapting the needed set of instructions 
from MTB. Toward this goal, the emerging picture of magnetosome assembly 
indicates that bifunctional proteins link one magnetosome component to the next, 
progressively defining the magnetosome compartment and biomineral. Until we 
Figure 2. 
Modelling magnetosome formation in prokaryotes and eukaryotes. In MTB, genetic encoding of magnetosomes 
begins with plasma membrane invagination to form an intracellular vesicle (A). Once formed, magnetosome 
membrane proteins located in this subcellular compartment initiate iron crystal formation (B). The full 
complement of magnetosome genes specifies the final composition, size, shape, and arrangement of mature 
biominerals (C). Unlike these prokaryotes, eukaryotic cells readily synthesize intracellular vesicles (denoted 
in A with a solid line). To designate a magnetosome-like compartment requires a subset of magnetosome 
genes, providing genetic information for the initiation of biomineralization (outlined in B with stipple). The 
transition from rudimentary magnetosome to mature nanoparticle (outlined in C with stipple) has not been 
fully elucidated in non-magnetic (e.g. mammalian) cells.
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can properly define how each genetic feature fits together, a rudimentary magneto-
some-like nanoparticle is likely to bridge the gap created by our partial understand-
ing of magnetosome biology. Since different cell types have different abilities for 
building and tolerating membrane-enclosed vesicles, research in this area should 
continue to expose fundamental processes involved in both magnetosome vesicle 
formation and iron biomineralization.
3. Iron biomineralization
Virtually all cells regulate iron carefully to prevent cellular damage from free 
radical formation all the while retaining access to a pool of iron co-factor, needed 
to drive vital cellular processes [36]. The magnetosome is a fine example of iron 
sequestration for the purpose of magnetite formation. This iron oxide (Fe3O4) 
has the necessary superparamagnetic properties for effective MRI detection [37]. 
Indeed, theoretical calculations indicate that approximately 3000 cells/voxel could 
be detected on large animal/human scanners at 3 Tesla if mammalian cells could 
be engineered to express the same magnetosomes as found in MTB [22]. On small 
animal scanners, this improves to as few as 3 cells/voxel. Therefore, a fuller under-
standing of how to regulate magnetosome formation will ultimately provide MR 
platforms with a sensitive and versatile method for long-term tracking of cells and 
their molecular activities.
Use of the magnetosome for this purpose in mammalian cells requires that some 
iron be diverted from its usual pathways of distribution, namely iron uptake, stor-
age and export [38]. Little is known about how iron uptake into a magnetosome-like 
vesicle will compete for the available cellular iron. Factors to consider include the 
cell’s labile iron pool and response to shifts in iron homeostasis. For example, the 
mouse, multi-potent P19 embryonic carcinoma cell line is an iron exporting cell 
type, with high iron import and export activities similar to alternatively activated 
macrophages [39]. This cell type is programmed to recycle iron and, as such, 
retains very low levels of iron storage. Furthermore, P19 iron export is hormonally 
regulated by hepcidin, which induces a transient decrease in iron export protein 
(ferroportin) and an increase in the relationship between MR transverse relaxation 
rates and total cellular iron. In addition to this endocrine response, P19 cells secrete 
hepcidin activity that effectively decreases ferroportin levels in human THP-1 
monocytes, indicating the ability for paracrine and/or autocrine regulation of cel-
lular iron content [40]. How will the formation of magnetosome-like particles affect 
iron homeostasis in multi-potent cells like P19?
Despite the complexity of P19 iron metabolism, we know the cell’s capacity for 
iron retention is increased by expression of the MTB gene magA [41]. This putative 
iron transporter [42, 43] has been localized to Golgi vesicles and sequesters iron in 
P19 cells regardless of competing iron export activity. In culture, MagA-derived 
activity depends on extracellular iron supplementation, potentially rerouting iron 
that is imported through the transferrin receptor and deposited in the labile iron 
pool, into a magnetosome-like storage vesicle. Presumably, this is indicative of the 
rudimentary magnetosome-like nanoparticle and the unique manner in which it 
may compartmentalize iron when further defined by the expression of essential 
magnetosome genes.
Early results with mammalian MamI-expressing cells indicate the same capacity 
for enhancing the iron-related MR transverse relaxation rates as MagA-expressing 
cells [32, 33]. In a direct comparison, using the same MDA-MB-435 host cell, both 
irreversible R2 and reversible R2′ components of the total R2* transverse relaxation 
rate (R2* = R2 + R2′) were affected. This is a remarkable result, considering how 
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different these two MTB proteins are. Apart from being integral membrane pro-
teins, they are vastly different sizes, have distinct genomic localization, and are 
opposites in terms of their supporting role in magnetosome biosynthesis. While 
MamI is essential, MagA is nonessential [44] as are the majority of magnetosome 
gene products [45], including the iron crystallizing protein Mms6 [21]. These 
results confirm that no one MTB or magnetosome-specific gene is sufficient for 
recreating the magnetosome structure. The iron biomineral is shaped within a 
membrane-enclosed compartment that not only imports iron but also creates the 
necessary environment for crystal formation, including maintaining the appropri-
ate pH and oxygen concentration for nucleation and crystallization. Once assembly 
of the basic magnetosome unit is understood, the possibility of genetically regulat-
ing crystal size, shape and composition [22] will have broad implications. Below, we 
identify features that impinge upon molecular imaging.
4. Applications in molecular imaging
The use of reporter genes to track molecular activity, and therefore cellular 
activity, is well known in biology. Reporter genes have provided all sorts of signals 
that may be detected optically under a microscope in cells or histological sections, 
or by using luminometry or chromatography on tissue extracts. Adapting reporter 
genes for non-invasive molecular imaging is an enabling technology that adds 
spatial information in the context of a living subject as well as the possibility of 
repetitive imaging for longitudinal study of in vivo processes. In addition, medical 
imaging is typically tomographic and may account for motion like heartbeat and 
respiration. On the other hand, there are added challenges for in vivo imaging, not 
the least of which involves reconciling cellular signals and tissue motion. Molecular 
signals are also frequently lost within large imaging volumes. While greater detail 
from smaller voxels may be resolved on scanners designed for small animals, these 
detection methods do not always scale up on large animal and human scanners, 
making translation from preclinical to clinical applications an ongoing challenge.
Nevertheless, the magnetosome is an interesting nanoparticle with multiple pos-
sible applications in molecular imaging. Magnetosomes may serve as a gene-based, 
contrast agent for tracking cell therapies without the need for exogenous substrate. 
By sequestering iron, the magnetosome is ideal for MR signal detection on various 
modalities, including MRI, hybrid imaging with positron emission tomography 
(PET)/MRI and MPI. The nature of the magnetosome biomineral may also be used 
to amplify and manipulate MR signals, by varying iron content and form [39]. For 
instance, in cultured P19 cells the negative regulation of iron export by hepcidin 
does little to increase total cellular iron; however, R2 is nevertheless more sensitive 
to hepcidin treatment than the untreated control. This study implicated changes 
in the form of intracellular iron (upon ferroportin degradation) and its influence 
on MR signal detection. Genetically encoded magnetosome components may also 
have yet unexplored applications, like using magnetosome vesicles as liposomes for 
ultrasound or for regulating iron overload by sequestering the excess mineral. Just 
as hybrid imaging combines more than one type of signal, e.g. co-localizing radio-
tracer and anatomical position [46], image-guidance may influence many aspects 
of medical care, e.g. delivering therapy and monitoring treatment [47]. It should be 
noted that MRI is a particularly versatile modality, with the capacity for multipara-
metric imaging [48, 49].
Adding gene-based contrast to this mix widens the scope of MR detection even 
further. Genetic regulation of nanoparticles [50] means that expression of the mag-
netosome can be tailored to include desirable features or exclude what is not needed. 
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For example, magnetosomes with genetically programmed, cell surface modifica-
tions have been prepared for a variety of applications from magnetic separation [51] 
to cancer diagnosis [52] and therapy [53]. In these examples, modified magneto-
somes are isolated from MTB, ensuring the biomineral is fully formed and has the 
expected magnetic properties. A breast cancer model was used to compare isolated 
magnetosomes with chemically synthesized SPIO coated with serum albumin [54]. 
Both types of nanoparticle were crosslinked with fluorescent-labelled antibody to 
the epidermal growth factor receptor and examined in cultured MDA-MB-231 cells 
and their tumour xenografts. The modified magnetosomes outperformed SPIO 
with respect to MR signal and tumour distribution. At high field strength, low 
doses of iron in purified magnetosomes gave higher R2 than an equivalent dose of 
the commercial SPIO, ferumoxide, and were suitable for MRI detection of rodent 
brain vasculature [55]. Following on this, genetically modified magnetosomes 
were used to locate glioblastoma in the rodent brain using purified magnetosomes 
expressing the RGD peptide fused to yellow fluorescent protein and MamC [52]. 
Others have successfully used purified magnetosomes for direct injection into 
rodent glioblastoma, at once treating with magnetic hyperthermia and monitor-
ing tumour shrinkage by MRI [56]. The strategy of using modified magnetosomes 
as exogenous contrast agents for molecular imaging has gained a measure of 
commercial success with the Magnelle reagent [57]. In all these examples, subcel-
lular arrangement of the magnetosome is an unnecessary feature since the iron 
biomineral is isolated from the bacterium. As such, the modified particles could be 
produced by mutant MTB that harbour only enough genetic information to recreate 
individual membrane-enclosed biominerals, devoid of attachments to cytoskeletal 
elements and each other. These modifications may facilitate purification and uptake 
of magnetosome-like nanoparticles into foreign hosts while reducing the possibil-
ity of unwanted immune response(s) in animal models, by limiting the number of 
exposed magnetosome proteins.
A compelling future strategy entails direct expression of rudimentary mag-
netosome-like nanoparticles in any cell type. Envisioning gene-based contrast of 
this nature for molecular imaging, using essential magnetosome genes to produce 
partially formed magnetosomes, is still under development (Figure 3). Clearly, 
MRI detects significant increases in mammalian cell contrast derived from single, 
Figure 3. 
Envisioning the rudimentary magnetosome-like nanoparticle. In any cell, essential magnetosome genes are 
expected to perform a central role in designating the point at which iron biomineralization will be initiated. 
The diagram depicts MamL in the role of magnetosome membrane designation, consistent with its ability 
to recruit MamI to the same intracellular particle. Incorporation of MamI initiates iron-handling activity, 
measured as an increase in MRI transverse relaxivity in iron-supplemented cells. Further MRI contrast 
enhancement is anticipated secondary to the recruitment of MamB and MamE iron-handling activities.
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MTB and magnetosome gene expression systems, including magA [58, 59], mms6 
[60, 61], and now the essential gene mamI [32]. MagA-derived MR contrast has also 
been studied in several rodent models, providing a measure of contrast enhance-
ment in xenografts of both tumour [62, 63] and stem [64] cells. Nevertheless, these 
single magnetosome gene expression systems fall short of the MR detection sen-
sitivity promised by a more mature nanoparticle. In addition, by underestimating 
the value of critical interactions between combinations of magnetosome proteins, 
there is not only the risk of losing iron biomineral fidelity but also encouraging 
unintended interactions with the foreign host. At present, what limits this technol-
ogy the most is our lack of appreciation for the fundamental magnetosome protein 
interactions that underlie the basic unit upon which the biomineral is structured. 
Noting the faithful interactions of MamI and MamL in mammalian cells, we expect 
that a minimum set of indispensable genes is involved in the biosynthesis of any 
magnetosome-like nanoparticle.
The combination of magnetosome genes that further elevates the MR signal 
is anxiously anticipated. Can we use the rudimentary magnetosome-like particle, 
consisting of essential magnetosome genes, to fashion nanoparticles that are MR 
silent until complemented by the protein(s) that trigger assembly of the complex 
or activation of biomineralization? Will subcellular arrangement of nanoparticles 
be sufficient to alter the MR signal? To what degree will changes in iron form or 
content alter MR detection? What types of cellular activity could be programmed to 
modulate magnetosome-like nanoparticle expression in mammalian cells?
4.1 Reporter gene expression
A special application of gene-based contrast is referred to as reporter gene 
expression. Basically, this is the difference between constant expression of the 
reporter gene versus its selective expression. Regions on DNA that promote gene 
expression (i.e. promoters, response elements, activating sequences) do so in 
response to protein-DNA interactions orchestrated by the cell. These transcrip-
tion factors (TF) may vary from cell type to cell type; however, the factors that 
stimulate common functions across all cells are often continually present and drive 
expression of vital functions. As such, expression constructs driving reporter gene 
transcription in response to ever present TF, provide constitutive expression of the 
reporter gene, which is akin to a cell label. The protein encoded by that reporter 
gene will label the cell throughout its life cycle and be faithfully reproduced in 
daughter cells. On the contrary, TF that distinguish one cell type from another are 
selectively expressed. These TF often drive expression of developmental genes that 
determine the stage of cellular differentiation and ultimate phenotype. These TF 
are neither active in every cell nor at all times in the cell’s history. For example, there 
are multiple TF that carry pluripotent stem cells toward terminal differentiation 
[12]. The phrase “reporter gene expression” was intended for this type of selective 
expression, which is often a defining feature of cellular activity in both health and 
disease and a valuable biomarker for molecular imaging.
Historically, most reporters are single gene expression systems that encode 
any protein for which there is a suitable means of detection. Of course, how the 
reporter signal is detected is intrinsically connected to the type of sample used 
for measurement and the available equipment. Luminometry using the reporter 
gene firefly luciferase, for example, began as a routine tool for the analysis of 
cell extracts but expanded to include small animal bioluminescence imaging 
once these scanners became available. For MR applications, however, single 
iron-handling reporter genes do not afford a large enough signal to be competi-
tive with chemically synthesized SPIO. Since the evidence in MTB indicates that 
Advances in Nanoparticle Research for Biomedical Applications
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iron biomineralization in vivo is a multi-step multi-component process, some 
consideration of multi-gene structures like the magnetosome is warranted. With 
this complexity, there may potentially be several types of reporter gene expression 
constructs that prove useful. For example, in mammalian cells, selective expres-
sion of anyone of the essential magnetosome genes could theoretically be used to 
regulate assembly of the magnetosome-like particle. Recently, a multi-component 
reporter gene construct has been described that is patterned on bacterial gas 
vesicles, to create an acoustic signal for ultrasound imaging [65]. A polycistronic 
DNA construct was subsequently prepared for mammalian cell expression, demon-
strating the feasibility of replicating a facsimile of the bacterial structure for small 
animal imaging [66].
The unique protein–protein interactions found in single-cell organisms like 
prokaryotes offer a unique opportunity to build reporter gene expression systems 
in eukaryotes that faithfully reproduce complex structures for non-invasive 
imaging modalities. The magnetosome is easily such a candidate, well-suited to 
MR signal detection platforms by virtue of its iron biomineral. Just what facsimile 
of this nanoparticle is required for a given application still needs to be properly 
defined. For MPI, uniform, well-formed iron crystals are required; however, 
genetically programming variations in biomineral size would provide distinct 
signals for reporter gene expression [22]. For MRI, there is a great deal of latitude 
in magnetosome-like particle detection, given the sensitivity of transverse relax-
ation rates to both the quantity and form of iron. Building reporter gene expression 
around multiple TF signals that successively add desirable features to the magne-
tosome-like particle, enhancing MR detection at each step, opens a new frontier in 
non-invasive imaging. This vision begins with the understanding of magnetosome 
root structure.
5. Conclusions
Medical imaging has transformed medical care: guiding diagnosis and the 
timely delivery of therapy, monitoring treatment success and avoiding unnecessary 
procedures. MRI, with its superior soft tissue resolution and depth of penetration 
in a non-ionizing form of radiation, is continually expanding its reach. To keep 
up with inroads in pre- and post-natal care [67, 68], pediatric MRI [69], specialty 
coils for the brain and cardiac imaging [46], as well as inserts for hybrid PET/
MRI [70], there is a continuing need to foster technological developments in 
MR-sensitive contrast agents. Cellular imaging is enabled by magnetic nanopar-
ticles. Furthermore, molecular imaging successes achieved with exogenous SPIO 
[47] indicate that future imaging with gene-based contrast is a realistic expectation. 
To this end, the magnetosome offers the necessary blueprint for patterning iron 
biomineralization in a safe and effective way.
Gene-based contrast permits greater understanding of a given disease process 
because it can be tied to the gene expression responsible for the cell’s behaviour, 
be this oncogenic, inflammatory, fibrotic, infectious, apoptotic, or the lack of 
appropriate signal transduction. While genetic regulation of contrast gene expres-
sion will initially pertain to preclinical research in animal models, many learnings 
will benefit clinically useful cell therapies either directly or indirectly. Microbiome 
research, for example, has already led to widely accepted probiotic supplements 
and experimental procedures like fecal microbiota transplantation [71]. Stem cell 
therapies are likewise destined to become mainstream. Developing the methods to 
visualize these therapies, deep within the body, is of paramount importance [72]. 
Holding back both microbial and mammalian cell therapies is an understanding of 
11
Molecular Imaging with Genetically Programmed Nanoparticles
DOI: http://dx.doi.org/10.5772/intechopen.96935
where these cells disseminate once introduced, how long they remain in the body, 
and how well they function. Molecular imaging of cellular activity holds the answer 
to many of these questions.
The introduction of multi-component assemblies as contrast agents for molecular 
imaging is an exciting new direction in nanoparticle research. Compared to single 
gene expression with injected contrast agent as substrate [73], multi-gene complexes 
offer a wider variety of imaging opportunities. For example, there may be no need 
for exogenous substrate, as assembly of the structure itself provides the imaging 
signal. In addition, there may be multiple levels of regulation, permitting finer 
control of assembly, disassembly and perhaps reassembly under the correct circum-
stances. This opens the possibility of creating suboptimal structures that are imaging 
silent until complemented by gene expression that switches on a detectable signal. 
Developing such structures could involve a role for constitutive and reporter gene 
expression. Further, by augmenting contrast incrementally, different stages of devel-
opment could be monitored in (stem) cells that fulfill their therapeutic mission by 
reaching a terminally differentiated phenotype. This would also permit troubleshoot-
ing cell therapies that fall short, including (re)programming the timing of signal 
detection to validate stages where therapeutic function was successfully delivered.
The magnetosome is formed in a multi-step process that is regulated by a cohort of 
essential and auxiliary proteins. The genes that encode this process sequester iron in a 
membrane-enclosed compartment, shaping the biomineral while protecting the cell 
from iron toxicity. Can other cells be taught how to synthesize a magnetosome-like 
nanoparticle? Research is steadily showing this is the case. What then are the essential 
components required in any cell to reproduce the main structure? The notion that a 
minimal root structure underlies magnetosome formation has been advanced. Are 
all features of the bacterial magnetosome necessary? The MR evidence indicates 
that select magnetosome genes provide a measure of contrast enhancement when 
individually expressed in mammalian cells. What then are the protein(s) required 
for biosynthesis of the most desirable MR signal(s)? As outlined in this chapter, the 
magnetosome genes that define this compartment are steadily being elucidated, 
demonstrating that iron biomineralization can be programmed in all types of cells.
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